The FDA is actively shaping future healthcare, clearing new drugs for melanoma and narcolepsy, and approving Moderna's mRNA flu vaccine despite past political challenges. Watch for impacts on patient access and pricing, as well as the FDA's evolving stance on manufacturing quality (ITM rejection) and AI integration following the recent demo day.